Findings of study suggest that for early-stage indolent PCBCL, no front-line treatment strategy that decreases the risk of recurrence is obvious. No difference in the risk of recurrence between conservative skin-directed and other therapies was observed.
Home / Resource Library / Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University